Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Cephalon Inc patents

Recent patent applications related to Cephalon Inc. Cephalon Inc is listed as an Agent/Assignee. Note: Cephalon Inc may have other listings under different names/spellings. We're not affiliated with Cephalon Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Cephalon Inc-related inventors

Use of reslizumab to treat moderate to severe eosinophilic asthma

Disclosed herein are methods of treating moderate to severe eosinophilic asthma in a patient comprising administering a therapeutically effective dose of reslizumab to the patient whose symptoms are inadequately controlled with a current asthma therapeutic and wherein the patient's blood eosinophil levels are equal to or greater than 400/μL.... Cephalon Inc

Affinity chromatography wash buffer

A wash buffer comprising greater than 0 mM and less than about 500 mM arginine, greater than 0 mM and less than about 250 mM guanidine, greater than 0 mM and less than about 250 mM sodium chloride, and greater than 0 mM and less than about 50 mM of... Cephalon Inc

Methods for preparing fused bicyclic 2, 4-diaminopyrimidine derivatives

The present disclosure is directed to improved methods useful for the preparation of, for example, 2-[[5-chloro-2-[[(6S)-6-[4-(2-hydroxyethyl)piperazin-1-yl]-1-methoxy-6,7,8,9-tetrahydro-5Hbenzo[7]annulen-2-yl]amino]pyrimidin-4-yl]amino]-N-methyl-benzamide (CEP-37440).... Cephalon Inc

Crystalline forms of parp inhibitors

The present disclosure relates to crystalline forms of 4,5,6,7-tetrahydro-11-methoxy-2-[(4-methyl-1-piperazinyl)methyl]-1H-cyclopenta[a]pyrrolo[3,4-c]carbazole-1,3(2H)-dione, including salts forms and free base forms.... Cephalon Inc

Fused bicyclic 2,4-diaminopyrimidine derivative as a dual alk and fak inhibitor

or a salt form thereof. The compound of formula (I) has ALK and FAK inhibitory activity, and may be used to treat proliferative disorders.... Cephalon Inc

Nanoparticulate and macroparticulate formulations

The present invention is directed to particles prepared via the polymerization of at least one surfactant and an isocyanate-containing compound. Pharmaceutical compositions prepared using these particles are also described.... Cephalon Inc

Antibodies that specifically bind to tl1a

Recombinantly expressed variant antibodies that have enhanced affinity for TL1A and enhanced potency relative to the parent antibody from which they were derived are provided. The antibodies inhibit the interaction between TL1A and the death receptor 3 (DR3). The antibodies, or a composition thereof, may be used to treat one... Cephalon Inc

Novel solid forms of bendamustine hydrochloride

Novel solid forms of bendamustine hydrochloride are described, as well as methods of their preparation and use.... Cephalon Inc

Macrocyclic compounds as alk, fak and jak2 inhibitors

or a pharmaceutically acceptable salt forms thereof, wherein R1, R2, R3, R4, R5, A and X are as defined herein, methods of treatment and uses thereof.... Cephalon Inc

Substituted aromatic sulfur compounds and methods of their use

wherein D, n, Ra, Rb, and Rc are as herein defined, along with pharmaceutical compositions and methods of using compounds of formula II for treating or reducing the risk of peritoneal carcinomatosis in a patient.... Cephalon Inc

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Cephalon Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Cephalon Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by